(R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity h5-HT1B/1D ligands

被引：5

作者：

Egle, I ^{[1
]}

MacLean, N ^{[1
]}

Demchyshyn, L ^{[1
]}

Edwards, L ^{[1
]}

Slassi, A ^{[1
]}

Tehim, A ^{[1
]}

机构：

[1] NPS Pharmaceut Inc, Mississauga, ON L4V 1V7, Canada

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 20期

关键词：

D O I：

10.1016/S0960-894X(03)00779-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of (R)- 3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives (2) have been prepared using parallel synthesis, and their structure-activity relationship studied. High affinity human 5-HT1B/1D (h5-HT1B/1D) ligands have been identified. (C) 2003 Elsevier Ltd. All rights reserved.

引用

收藏

页码：3419 / 3421

页数：3

相关论文

共 16 条

[1] Advances in pharmacological treatment of migraine [J].

Diener, HC ;

Limmroth, V .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (10) :1831-1845

[2] THE DEVELOPMENT OF A HIGHLY SELECTIVE 5-HT(1) RECEPTOR AGONIST, SUMATRIPTAN, FOR THE TREATMENT OF MIGRAINE [J].

FENIUK, W ;

HUMPHREY, PPA .

DRUG DEVELOPMENT RESEARCH, 1992, 26 (03) :235-240

[3] 5-HT1 RECEPTORS IN MIGRAINE PATHOPHYSIOLOGY AND TREATMENT [J].

FERRARI, MD ;

SAXENA, PR .

EUROPEAN JOURNAL OF NEUROLOGY, 1995, 2 (01) :5-21

[4]

*GLAX WELLC INC, 2001, PHYS DESK REF, P1399

[5] THE MODE OF ACTION OF SUMATRIPTAN IS VASCULAR - A DEBATE [J].

HUMPHREY, PPA ;

GOADSBY, PJ .

CEPHALALGIA, 1994, 14 (06) :401-410

[6]

Isaac M, 2001, IDrugs, V4, P189

[7]

KAMBOJ R, 1999, IBCS 3 ANN C MIGR NO

[8] Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system:: Implications for the discovery of new antimigraine drugs [J].

Longmore, J ;

Shaw, D ;

Smith, D ;

Hopkins, R ;

McAllister, G ;

Pickard, JD ;

Sirinathsinghji, DJS ;

Butler, AJ ;

Hill, RG .

CEPHALALGIA, 1997, 17 (08) :833-842

[9]

Longmore J., 1999, CURR OPIN CPNS INVES, V1, P39

[10] SYNTHESIS AND SEROTONERGIC PHARMACOLOGY OF THE ENANTIOMERS OF 3-[(N-METHYLPYRROLIDIN-2-YL)METHYL]-5-METHOXY-1H-INDOLE - DISCOVERY OF STEREOGENIC DIFFERENTIATION IN THE AMINOETHYL SIDE-CHAIN OF THE NEUROTRANSMITTER SEROTONIN [J].

MACOR, JE ;

BLAKE, J ;

FOX, CB ;

JOHNSON, C ;

KOE, BK ;

LEBEL, LA ;

MORRONE, JM ;

RYAN, K ;

SCHMIDT, AW ;

SCHULZ, DW ;

ZORN, SH .

JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) :4503-4505